Procurement of a Novel SMA/SCID Test Solution
Children's Health Ireland (CHI)
Synopsis
Lifecycle advised Children’s Health Ireland (CHI) to design and manage the end-to-end procurement process for a novel test solution supporting Spinal Muscular Atrophy (SMA) and Severe Combined Immunodeficiency (SCID) in newborn screening. This initiative was critical to advancing national service provision for children’s health, ensuring early detection and integration into existing workflows and IT infrastructure. The headings below provide a structured summary of the delivered project and key achievements.
Clinical and Scientific Engagement
- Conducted extensive reviews with clinical and scientific stakeholders to develop the user requirement specification.
- Established consensus on equipment service requirements for the laboratory
- Ensured alignment with international best practices for the provision of equipment and methodologies.
Documentation and Process Management
- Drafted and managed all procurement documentation, ensuring compliance with national and EU procurement regulations.
- Coordinated timelines, milestones, and communication with stakeholders.
- Oversaw and managed the transparent running of the procurement process.
Procurement Strategy and Market Soundings
- Designed a robust procurement methodology tailored to the novel test solution.
- Undertook market soundings to assess supplier capabilities and readiness.
- Identified potential vendors and validated technical feasibility.
Evaluation and Outcome Management
- Facilitated technical and financial evaluations with a professional evaluation group.
- Applied structured scoring mechanisms including moderations to ensure fairness and objectivity.
- Managed deliberations leading to the preferred supplier outcome.
Contracting and Handover
- Negotiated final contract terms and secured signatures.
- Established clear handover protocols to the implementation team.
- Ensured contractual obligations supported seamless integration into existing workflows.
Conclusion
Through structured engagement, rigorous procurement management, and seamless integration planning, Lifecycle successfully supported Children’s Health Ireland in adopting a novel SMA/SCID test solution. This case highlights Lifecycle’s proven expertise in delivering complex healthcare procurement projects, balancing scientific requirements, regulatory compliance, and operational integration in a clinical laboratory setting.
The service has now moved beyond procurement being fully implemented, with patient testing underway—an achievement that underscores the effectiveness of the partnership between Lifecycle and CHI and its tangible impact on advancing newborn screening services.
“Children’s Health Ireland commended Lifecycle for expertly managing the end-to-end procurement of the novel SMA/SCID newborn screening equipment solution, ensuring seamless integration into national laboratory services.”